VALIDATION OF THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM AND TRANSPLANTATION RISK INDEX ON POSTTRANSPLANTATION OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

被引：0
|
作者：
Yahng, S. [1 ]
Jeon, Y. W. [2 ]
Yoon, J. H. [2 ]
Shin, S. H. [3 ]
Lee, S. E. [2 ]
Choi, Y. S. [4 ]
Kim, D. Y. [4 ]
Lee, J. H. [4 ]
Eom, K. S. [2 ]
Lee, S. [2 ]
Min, C. K. [2 ]
Kim, H. J. [2 ]
Lee, J. W. [2 ]
Lee, K. H. [4 ]
Min, W. S. [2 ]
Lee, J. H. [4 ]
Kim, Y. J. [2 ]
机构：
[1] Catholic Univ Korea, Incheon St Marys Hosp, Hematol, Inchon, South Korea
[2] Catholic Univ Korea, Hematol, Catholic Blood & Marrow Transplantat Ctr, Seoul St Marys Hosp, Seoul, South Korea
[3] Catholic Univ Korea, Yeoido St Marys Hosp, Hematol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Hematol, Seoul, South Korea
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30260-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
259
引用
收藏
页码：S129 / S130
页数：3
相关论文
共 50 条
  • [21] Incorporation of Mutations and Bone Marrow Fibrosis into the Revised International Prognostic Scoring System in Patients with Myelodysplastic Syndromes
    Zhao, Youshan
    Chang, ChunKang
    BLOOD, 2022, 140 : 4063 - 4064
  • [22] Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes
    Montoro, Julia
    Pomares, Helena
    Villacampa, Guillermo
    Merchan, Brayan
    Molero, Antonieta
    Alonso, Esther
    Gallur, Laura
    Grau, Javier
    Salamero, Olga
    Roldan, Elisa
    Saumell, Silvia
    Ortega, Margarita
    Sureda, Anna
    Bosch, Francesc
    Arnan, Montserrat
    Valcarcel, David
    LEUKEMIA & LYMPHOMA, 2019, 60 (06) : 1522 - 1527
  • [23] REPORT ON OUTCOME OF HYPOMETHYLATING THERAPY WITH ANALYSIS ON PROGNOSTIC VALUE OF REVISED-INTERNATIONAL PROGNOSTIC SCORING SYSTEM IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES OF LOWER-RISK BASED ON IPSS
    Lee, Y.
    Moon, J.
    Yoon, J.
    Kim, J.
    Sohn, S.
    HAEMATOLOGICA, 2016, 101 : 507 - 507
  • [24] Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes
    Yoo Jin Lee
    Sung Woo Park
    In Hee Lee
    Jae Sook Ahn
    Hyeoung Joon Kim
    Joo Seop Chung
    Ho Jin Shin
    Won Sik Lee
    Sang Min Lee
    Young Don Joo
    Hawk Kim
    Ho Sup Lee
    Yang Soo Kim
    Yoon Young Cho
    Joon Ho Moon
    Sang Kyun Sohn
    Annals of Hematology, 2016, 95 : 1795 - 1804
  • [25] Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes
    Lee, Yoo Jin
    Park, Sung Woo
    Lee, In Hee
    Ahn, Jae Sook
    Kim, Hyeoung Joon
    Chung, Joo Seop
    Shin, Ho Jin
    Lee, Won Sik
    Lee, Sang Min
    Joo, Young Don
    Kim, Hawk
    Lee, Ho Sup
    Kim, Yang Soo
    Cho, Yoon Young
    Moon, Joon Ho
    Sohn, Sang Kyun
    ANNALS OF HEMATOLOGY, 2016, 95 (11) : 1795 - 1804
  • [26] Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System
    van Spronsen, Margot F.
    Ossenkoppele, Gert J.
    Westers, Theresia M.
    van de Loosdrecht, Arjan A.
    EUROPEAN JOURNAL OF CANCER, 2016, 56 : 10 - 20
  • [27] Validation of the Lower Risk MD Anderson Prognostic Scoring System for Patients with Myelodysplastic Syndromes (MDS)
    Ramadan, Hanadi
    Corrales-Yepez, Maria
    Ali, Najla
    Zhang, Ling
    Padron, Eric
    Lancet, Jeffrey
    List, Alan
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S232 - S233
  • [28] Application of the international Prognostic Scoring System for myelodysplastic syndromes
    Maes, B
    Meeus, P
    Michaux, L
    Bijnens, L
    Boogaerts, M
    Hagemeijer, A
    De Wolf-Peeters, C
    Verhoef, G
    ANNALS OF ONCOLOGY, 1999, 10 (07) : 825 - 829
  • [29] The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromes
    Nazha, Aziz
    Seastone, David P.
    Keng, Michael
    Hobson, Sean
    Kalaycio, Matt
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    LEUKEMIA & LYMPHOMA, 2015, 56 (12) : 3437 - 3439
  • [30] The Revised International Prognostic Scoring System (IPSS-R) Predicts Posttransplantation Outcome Of Patients With Myelodysplastic Syndrome Receiving Allogeneic Stem Cell Transplantation: A Basis For Clinical Decision Making
    Della Porta, Matteo G.
    Alessandrino, Emilio Paolo
    Bacigalupo, Andrea
    Allione, Bernardino
    Malcovati, Luca
    van Lint, Maria Teresa
    Bernardi, Massimo
    Onida, Francesco
    Bosi, Alberto
    Iori, Anna Paola
    Cerretti, Raffaella
    Marenco, Paola
    Pioltelli, Pietro
    Angelucci, Emanuele
    Oneto, Rosi
    Pascutto, Cristiana
    Cazzola, Mario
    Rambaldi, Alessandro
    BLOOD, 2013, 122 (21)
12345